Conning Inc. Has $416,000 Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Conning Inc. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 579 shares of the biopharmaceutical company’s stock after selling 70 shares during […]

Related Keywords

Roberte Landry ,Arthurf Ryan , ,News Ratings For Regeneron Pharmaceuticals Daily ,Nasdaq ,Exchange Commission ,Morgan Stanley ,Regeneron Pharmaceuticals ,Baird Financial Group Inc ,Regeneron Pharmaceuticals Stock Down ,Canaccord Genuity Group ,Wells Fargo Company ,Quarter For Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Inc ,Markel Corp ,Cibc World Market Inc ,Securities Exchange Commission ,Sequoia Financial Advisors ,Blair William Co ,Free Report ,World Market ,Financial Advisors ,Baird Financial Group ,Financial Group ,Genuity Group ,Pharmaceuticals Stock Down ,Get Free Report ,Director Arthur ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,